None listed
Conditions
Interventions
Others(A (AUL NiacinGold Sun Screen) and B (non-treated control site) comparison) : In this study, each subject's back was divided into two test sites. One site was designated as the test site and tre
Sponsors
Human Co., Ltd. Skin Clinical Trial Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Healthy Korean male and female adults over the age of 19 - Subjects who have signed a consent form voluntarily after being informed sufficiently on the objectives of study and all related contents - Subjects who are healthy without acute and chronic diseases including skin disorders - Subjects who can be observed and traced throughout the entire study period
Exclusion criteria
Exclusion criteria: - Subjects who are pregnant, breastfeeding, or planning a pregnancy - Subjects who have psychiatric disease and infectious skin disease - Subjects who have used an ointment containing steroids for more than 1 month - Subjects who participated in the similar test within the past 6 months - Subjects who have sensitive and hypersensitive skin - Subjects who have abnormal skin findings at the test site, including moles, acne, erythema, or telangiectasia. - Subjects who have used cosmetics or drugs on the test site with same efficacy within the past 3 months - Subjects who have undergone dermatological treatment or procedures (e.g., liposuction, laser treatment, ultrasound lipolysis, or other skin care procedures) on the test site within the past 6 months - Subjects who are employees of the Sponsor - Subjects deemed by the principal investigator to be unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UV-damaged skin barrier;UV-induced skin redness | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy self report questionnaire;Assessment of skin Adverse Event (AE) | — |
Countries
Korea, Republic of
Contacts
Public ContactKim Su Yeoung
Human Co., Ltd. Skin Clinical Trial Center
Outcome results
None listed